Oxford halts dosing in trial of AstraZeneca COVID vaccine in children, teenagers

In an official statement, the university said that it is awaiting the results of a safety review from UK regulators, the Medicines and Healthcare products Regulatory Agency (MHRA), as reported by the Hill.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2RdMyNn
via IFTTT

0 comments:

Post a Comment